|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of BioAtla (NASDAQ: BCAB) through any online brokerage.
There are no as such competitors for BioAtla.
The latest price target for BioAtla (NASDAQ: BCAB) was reported by Roth Capital on June 28, 2021. The analyst firm set a price target for 75.00 expecting BCAB to rise to within 12 months (a possible 85.83% upside). 6 analyst firms have reported ratings in the last year.
The stock price for BioAtla (NASDAQ: BCAB) is $40.36 last updated Today at 8:00:02 PM.
There are no upcoming dividends for BioAtla.
There is no upcoming split for BioAtla.
BioAtla is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.